Back to Search
KAKNEKA MASON, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1689708281Individual
Specialties, Licenses & Credentials
Research & Publications (20)
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
PMID 17628743·Invest New Drugs·2008
7-preclinical
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
PMID 16905212·Radiother Oncol·2006
7-preclinical
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
PMID 15234054·Int J Radiat Oncol Biol Phys·2004
7-preclinical
Biology-based combined-modality radiotherapy: workshop report.
PMID 11429236·Int J Radiat Oncol Biol Phys·2001
7-preclinical
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
PMID 11179493·Int J Oncol·2001
7-preclinical
The 2005 Wellington influenza outbreak: syndromic surveillance of Wellington Hospital Emergency Department activity may have provided early warning.
PMID 19630852·Aust N Z J Public Health·2009
8-other
Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae.
PMID 19500108·Cell Microbiol·2009
7-preclinical
The role of feticide in the context of late termination of pregnancy: a qualitative study of health professionals' and parents' views.
PMID 19557834·Prenat Diagn·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1221 MERCANTILE LN
LARGO, MD 20774 - Phone
- (301) 618-5527
Quick Facts
- NPI
- 1689708281
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile